Sign In
Buy LLY
$1,169.86
+53.75 (+4.82%)
At Close: Aug 05, 2026
GSK and Eli Lilly are the latest to unveil plans to add to manufacturing and increase other operations in America.
Why the Market Dipped But Eli Lilly (LLY) Gained Today
06:46pm, Tuesday, 16'th Sep 2025
Eli Lilly (LLY) concluded the recent trading session at $763.57, signifying a +2.06% move from its prior day's close.
Why Eli Lilly Stock Was a Winner Today
06:15pm, Tuesday, 16'th Sep 2025
A hopeful report about a potential blockbuster drug currently in development and news of an expansion of manufacturing capability helped push Eli Lilly (LLY 2.09%) stock skyward on Tuesday. Shares of
Lilly CEO: U.K. has gone from biopharma leader to laggard
06:02pm, Tuesday, 16'th Sep 2025
Lilly CEO Dave Ricks explains why pricing dynamics in the U.K. make it a very unattractive place for Lilly to invest.
Trump Drug Ad Crackdown: FDA Warns Novo Nordisk, Eli Lilly, Hims
04:45pm, Tuesday, 16'th Sep 2025
The Food and Drug Administration sent warning letters to dozens of drug companies— including popular telehealth firm Hims & Hers and pharmaceutical giants Eli Lilly and Novo Nordisk— demanding the
FDA Flags Eli Lilly's Weight-Loss Drug Video For Misleading Claims
02:10pm, Tuesday, 16'th Sep 2025
The U.S. Food and Drug Administration (FDA) has determined that a promotional video featuring Zepbound and Mounjaro (tirzepatide), both produced by Eli Lilly And Co. LLY, is false or misleading.
Eli Lilly to invest $5B on Virginia plant amid Trump's pharma tariff threats
01:51pm, Tuesday, 16'th Sep 2025
Pharmaceutical giant Eli Lilly expanded its Virginia facility investment plans to $5 billion from original $2.1 billion amid the Trump administration tariff threats on drug imports.
This weight-loss pill by Lilly could be FDA-approved by end of 2025
12:21pm, Tuesday, 16'th Sep 2025
Eli Lilly's experimental weight-loss pill could be fast-tracked under a one- to two-month review process recently launched by the U.S. Food and Drug Administration, several Wall Street analysts said.
Eli Lilly to build $5B Virginia site to boost production of targeted cancer drugs, other treatments
11:36am, Tuesday, 16'th Sep 2025
Eli Lilly on Tuesday said it will spend $5 billion to build a manufacturing facility in Goochland County, Virginia, to boost production capacity for targeted cancer drugs and other treatments — the
Eli Lilly unveils plans for $5B manufacturing facility near Richmond, Virginia
11:16am, Tuesday, 16'th Sep 2025
CNBC's Angelica Peebles reports on news regarding Eli Lilly.
Eli Lilly to Invest $5 Billion in New Virginia Drug Manufacturing Plant
11:05am, Tuesday, 16'th Sep 2025
Plan is part of the drugmaker's pledge to bolster its domestic medicine production with four new pharmaceutical manufacturing sites.
Eli lilly to invest $5 billion in new Virginia plant as pharma braces for tariffs
10:33am, Tuesday, 16'th Sep 2025
Eli Lilly said on Tuesday it will invest $5 billion to build a manufacturing facility in Virginia, the first of four new U.S. plants the drugmaker has planned as it moves to expand domestic production
UK has gone from a leader to a laggard in biopharma, Eli Lilly CEO says
10:30am, Tuesday, 16'th Sep 2025
Eli Lilly & Co. CEO Dave Ricks says the U.K. has gone from biopharmaceutical leader to laggard. Lilly is among a handful of biopharma companies that have put investments in the U.K. on hold amid conce
Eli Lilly to build $5 billion Virginia facility to boost production of targeted cancer drugs, other treatments
10:30am, Tuesday, 16'th Sep 2025
Eli Lilly on Tuesday said it will spend $5 billion to build a manufacturing facility in Goochland County, Virginia, to boost production capacity for targeted cancer drugs and other treatments. The pla
Lilly announces plans to build $5 billion manufacturing facility in Virginia
10:30am, Tuesday, 16'th Sep 2025
New site in Virginia's Goochland County will develop active pharmaceutical ingredients (API) in the U.S. for cancer, autoimmune and other advanced therapies Company will create 2,450 high-wage manufac
